ARK Investment Management LLC 13D and 13G filings for Adaptive Biotechnologies Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-06-06 1:40 pm Sale |
2025-05-31 | 13G | Adaptive Biotechnologies Corporation ADPT |
ARK Investment Management LLC | 4,398,669 2.900% |
-3,333,901 (-43.12%) |
Filing |
| 2025-05-14 10:34 am Purchase |
2025-03-31 | 13G | Adaptive Biotechnologies Corporation ADPT |
ARK Investment Management LLC | 7,732,570 5.200% |
1,664,761 (+27.44%) |
Filing |
| 2025-05-07 11:42 am Sale |
2025-04-30 | 13G | Adaptive Biotechnologies Corporation ADPT |
ARK Investment Management LLC | 6,067,809 3.990% |
-3,356,265 (-35.61%) |
Filing |
| 2025-02-14 11:23 am Sale |
2024-12-31 | 13G | Adaptive Biotechnologies Corporation ADPT |
ARK Investment Management LLC | 9,424,074 6.390% |
-3,382,439 (-26.41%) |
Filing |
| 2024-01-29 4:00 pm Purchase |
2023-12-31 | 13G | Adaptive Biotechnologies Corporation ADPT |
ARK Investment Management LLC | 12,806,513 8.850% |
3,605,268 (+39.18%) |
Filing |
| 2023-02-10 10:25 am Purchase |
2022-12-31 | 13G | Adaptive Biotechnologies Corporation ADPT |
ARK Investment Management LLC | 9,201,245 6.430% |
9,201,245 (New Position) |
Filing |